{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:08:44Z","timestamp":1785424124859,"version":"3.56.0"},"reference-count":45,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Naval Medical Research Command\u2019s Naval Advanced Medical Development Program","award":["MT21010.006"],"award-info":[{"award-number":["MT21010.006"]}]},{"name":"Combat Readiness\u2014Medical Research Program","award":["W81XWH-21-2-0018"],"award-info":[{"award-number":["W81XWH-21-2-0018"]}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-010709"],"award-info":[{"award-number":["INV-010709"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"award":["INV-010709"],"award-info":[{"award-number":["INV-010709"]}],"id":[{"id":"https:\/\/ror.org\/0456r8d26","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Background\/Objectives: Enterotoxigenic Escherichia coli (ETEC) is a leading cause of diarrheal illness worldwide, resulting in approximately 380,000 deaths annually, with significant morbidity in children and travelers to endemic regions. ETEC infection begins with the attachment of the bacterium to the small intestine via filamentous colonization factors (CF), followed by the production of heat-labile (LT) and heat-stable (ST) toxins that induce watery diarrhea. Targeting CF to prevent ETEC attachment is challenging due to strain heterogeneity. Methods: In previous studies, we developed a class-switched human monoclonal antibody, 68\u201390, expressed as secretory IgA (SIgA) in rice for cost-effective and stable storage. Rice-produced SIgA exhibited comparable binding efficiency to CfaE, a component of CF, compared to CHO-produced SIgA in vitro. Results: In this work, we showed that oral administration of 68\u201390 SIgA to Aotus nancymaae did not alter gut microbiome distribution or show signs of systemic exposure. Conclusions: These findings suggest that oral delivery of ETEC-specific SIgA is safe and does not disrupt the gut microbial population, highlighting its potential as an effective and targeted therapeutic strategy.<\/jats:p>","DOI":"10.3390\/pharmaceutics18040457","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:56:07Z","timestamp":1775724967000},"page":"457","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Oral Pre-Exposure Secretory IgA Prophylactic Produced in Rice on Gut Microbiome Homeostasis"],"prefix":"10.3390","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1154-3858","authenticated-orcid":false,"given":"Ravi","family":"Bharadwaj","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3796-2074","authenticated-orcid":false,"given":"Carlos","family":"Gaspar","sequence":"additional","affiliation":[{"name":"Vysnova Partners LLC, Alexandria, VA 22314, USA"},{"name":"U.S. Naval Medical Research Unit SOUTH, Lima 07031, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2912-2621","authenticated-orcid":false,"given":"Tyler D.","family":"Moeller","sequence":"additional","affiliation":[{"name":"U.S. Naval Medical Research Unit SOUTH, Lima 07031, Peru"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4952-824X","authenticated-orcid":false,"given":"Doyle","family":"Ward","sequence":"additional","affiliation":[{"name":"Department of Microbiology and Physiological Systems, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S.","family":"Klempner","sequence":"additional","affiliation":[{"name":"Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1417-8339","authenticated-orcid":false,"given":"Lisa A.","family":"Cavacini","sequence":"additional","affiliation":[{"name":"Division of Innate Immunity, Department of Medicine, University of Massachusetts Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e321","DOI":"10.1016\/S2214-109X(18)30483-2","article-title":"Burden of enterotoxigenic Escherichia coli and shigella non-fatal diarrhoeal infections in 79 low-income and lower middle-income countries: A modelling analysis","volume":"7","author":"Anderson","year":"2019","journal-title":"Lancet Glob. Health"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S232","DOI":"10.1093\/cid\/cis753","article-title":"The Global Enteric Multicenter Study (GEMS) of diarrheal disease in infants and young children in developing countries: Epidemiologic and clinical methods of the case\/control study","volume":"55","author":"Kotloff","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/S0140-6736(16)31529-X","article-title":"Use of quantitative molecular diagnostic methods to identify causes of diarrhoea in children: A reanalysis of the GEMS case-control study","volume":"388","author":"Liu","year":"2016","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40794-018-0077-1","article-title":"Travelers\u2019 diarrhea: Update on the incidence, etiology and risk in military and similar populations\u20141990\u20132005 versus 2005\u20132015, does a decade make a difference?","volume":"5","author":"Olson","year":"2019","journal-title":"Trop. Dis. Travel Med. Vaccines"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1128\/CMR.18.3.465-483.2005","article-title":"Enterotoxigenic Escherichia coli in developing countries: Epidemiology, microbiology, clinical features, treatment, and prevention","volume":"18","author":"Qadri","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/bs.aambs.2014.09.003","article-title":"Colonization factors of enterotoxigenic Escherichia coli","volume":"90","author":"Madhavan","year":"2015","journal-title":"Adv. Appl. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1128\/mr.60.1.167-215.1996","article-title":"Enteric bacterial toxins: Mechanisms of action and linkage to intestinal secretion","volume":"60","author":"Sears","year":"1996","journal-title":"Microbiol. Rev."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1586\/erv.12.37","article-title":"Progress and hurdles in the development of vaccines against enterotoxigenic Escherichia coli in humans","volume":"11","author":"Zhang","year":"2012","journal-title":"Expert Rev. Vaccines"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1128\/IAI.01394-13","article-title":"Characterization of heat-stable (STa) toxoids of enterotoxigenic Escherichia coli fused to double mutant heat-labile toxin peptide in inducing neutralizing Anti-STa antibodies","volume":"82","author":"Ruan","year":"2014","journal-title":"Infect. Immun."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"7190","DOI":"10.1128\/IAI.72.12.7190-7201.2004","article-title":"Evolutionary and functional relationships of colonization factor antigen i and other class 5 adhesive fimbriae of enterotoxigenic Escherichia coli","volume":"72","author":"Anantha","year":"2004","journal-title":"Infect. Immun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1016\/j.vaccine.2011.06.084","article-title":"A systematic review of ETEC epidemiology focusing on colonization factor and toxin expression","volume":"29","author":"Isidean","year":"2011","journal-title":"Vaccine"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/IAI.00497-09","article-title":"Genetic fusions of heat-labile (LT) and heat-stable (ST) toxoids of porcine enterotoxigenic Escherichia coli elicit neutralizing anti-LT and anti-STa antibodies","volume":"78","author":"Zhang","year":"2010","journal-title":"Infect. Immun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/00365521.2011.574726","article-title":"Randomized control trials using a tablet formulation of hyperimmune bovine colostrum to prevent diarrhea caused by enterotoxigenic Escherichia coli in volunteers","volume":"46","author":"Otto","year":"2011","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1056\/NEJM198805123181904","article-title":"Protection by milk immunoglobulin concentrate against oral challenge with enterotoxigenic Escherichia coli","volume":"318","author":"Tacket","year":"1988","journal-title":"N. Engl. J. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"e00355-18","DOI":"10.1128\/IAI.00355-18","article-title":"Identification and Characterization of Human Monoclonal Antibodies for Immunoprophylaxis Against Enterotoxigenic Escherichia coli Infection","volume":"86","author":"Giuntini","year":"2018","journal-title":"Infect. Immun."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.vaccine.2020.01.064","article-title":"Oral administration of an anti-CfaE secretory IgA antibody protects against Enterotoxigenic Escherichia coli diarrheal disease in a nonhuman primate model","volume":"38","author":"Stoppato","year":"2020","journal-title":"Vaccine"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1042\/BCJ20160510","article-title":"Introduction to the human gut microbiota","volume":"474","author":"Thursby","year":"2017","journal-title":"Biochem. J."},{"key":"ref_18","first-page":"101","article-title":"Role of gut microbiota in the pathogenesis of colorectal cancer; a review article","volume":"11","author":"Alebouyeh","year":"2018","journal-title":"Gastroenterol. Hepatol. Bed Bench"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/s41598-019-56561-1","article-title":"FBA Ecological Guild: Trio of Firmicutes-Bacteroidetes Alliance against Actinobacteria in Human Oral Microbiome","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.phrs.2018.04.009","article-title":"Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism","volume":"133","author":"Enright","year":"2018","journal-title":"Pharmacol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/03602532.2018.1497647","article-title":"Gut microbiota modulates drug pharmacokinetics","volume":"50","author":"Zhang","year":"2018","journal-title":"Drug Metab. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.apsb.2019.01.004","article-title":"Multifunctional oral delivery systems for enhanced bioavailability of therapeutic peptides\/proteins","volume":"9","author":"Han","year":"2019","journal-title":"Acta Pharm. Sin. B"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nature25979","article-title":"Extensive impact of non-antibiotic drugs on human gut bacteria","volume":"555","author":"Maier","year":"2018","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"pgac063","DOI":"10.1093\/pnasnexus\/pgac063","article-title":"SLC46A3 is a lysosomal proton-coupled steroid conjugate and bile acid transporter involved in transport of active catabolites of T-DM1","volume":"1","author":"Tomabechi","year":"2022","journal-title":"PNAS Nexus"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e02347-19","DOI":"10.1128\/AAC.02347-19","article-title":"Antibacterial Monoclonal Antibodies Do Not Disrupt the Intestinal Microbiome or Its Function","volume":"64","author":"Tovchigrechko","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Schierova, D., Roubalova, R., Kolar, M., Stehlikova, Z., Rob, F., Jackova, Z., Coufal, S., Thon, T., Mihula, M., and Modrak, M. (2021). Fecal Microbiome Changes and Specific Anti-Bacterial Response in Patients with IBD during Anti-TNF Therapy. Cells, 10.","DOI":"10.3390\/cells10113188"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jbiotec.2014.02.005","article-title":"A rice-based soluble form of a murine TNF-specific llama variable domain of heavy-chain antibody suppresses collagen-induced arthritis in mice","volume":"175","author":"Abe","year":"2014","journal-title":"J. Biotechnol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Sasou, A., Yuki, Y., Kurokawa, S., Sato, S., Goda, Y., Uchida, M., Matsumoto, N., Sagara, H., Watanabe, Y., and Kuroda, M. (2021). Development of Antibody-Fragment-Producing Rice for Neutralization of Human Norovirus. Front. Plant Sci., 12.","DOI":"10.3389\/fpls.2021.639953"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: A flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nmeth.1923","article-title":"Fast gapped-read alignment with Bowtie 2","volume":"9","author":"Langmead","year":"2012","journal-title":"Nat. Methods"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"e65088","DOI":"10.7554\/eLife.65088","article-title":"Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3","volume":"10","author":"Beghini","year":"2021","journal-title":"eLife"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1038\/s41587-019-0209-9","article-title":"Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2","volume":"37","author":"Bolyen","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"9351507","DOI":"10.1155\/2017\/9351507","article-title":"Proteobacteria: A Common Factor in Human Diseases","volume":"2017","author":"Rizzatti","year":"2017","journal-title":"BioMed Res. Int."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Corth\u00e9sy, B., Monnerat, J., L\u00f6tscher, M., Vonarburg, C., Schaub, A., and Bioley, G. (2018). Oral Passive Immunization With Plasma-Derived Polyreactive Secretory-Like IgA\/M Partially Protects Mice Against Experimental Salmonellosis. Front. Immunol., 9.","DOI":"10.3389\/fimmu.2018.02970"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"11809","DOI":"10.1073\/pnas.1301975110","article-title":"Orally fed seeds producing designer IgAs protect weaned piglets against enterotoxigenic Escherichia coli infection","volume":"110","author":"Virdi","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41587-019-0070-x","article-title":"Yeast-secreted, dried and food-admixed monomeric IgA prevents gastrointestinal infection in a piglet model","volume":"37","author":"Virdi","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/infdis\/jix144","article-title":"Prophylactic Efficacy of Hyperimmune Bovine Colostral Antiadhesin Antibodies Against Enterotoxigenic Escherichia coli Diarrhea: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial","volume":"216","author":"Savarino","year":"2017","journal-title":"J. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/infdis\/jiz135","article-title":"Hyperimmune Bovine Colostral Anti-CS17 Antibodies Protect Against Enterotoxigenic Escherichia coli Diarrhea in a Randomized, Doubled-Blind, Placebo-Controlled Human Infection Model","volume":"220","author":"Savarino","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1053\/j.gastro.2013.06.053","article-title":"Anti-rotavirus protein reduces stool output in infants with diarrhea: A randomized placebo-controlled trial","volume":"145","author":"Sarker","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Peterfreund, G.L., Vandivier, L.E., Sinha, R., Marozsan, A.J., Olson, W.C., Zhu, J., and Bushman, F.D. (2012). Succession in the Gut Microbiome following Antibiotic and Antibody Therapies for Clostridium difficile. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0046966"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1128\/CDLI.6.4.537-541.1999","article-title":"Effect of Antiflagellar Human Monoclonal Antibody on Gut-Derived Pseudomonas aeruginosa Sepsis in Mice","volume":"6","author":"Matsumoto","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"key":"ref_42","first-page":"e00456-16","article-title":"Antibody-Based Immunotherapy To Treat and Prevent Infection with Hypervirulent Klebsiella pneumoniae","volume":"24","author":"Sun","year":"2017","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.1038\/s41598-022-10450-2","article-title":"Microbial changes in stool, saliva, serum, and urine before and after anti-TNF-\u03b1 therapy in patients with inflammatory bowel diseases","volume":"12","author":"Park","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"D\u2019ambrosio, A., Altomare, A., Boscarino, T., Gori, M., Balestrieri, P., Putignani, L., Del Chierico, F., Carotti, S., Cicala, M., and Guarino, M.P.L. (2024). Mathematical Modeling of Vedolizumab Treatment\u2019s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients. Bioengineering, 11.","DOI":"10.3390\/bioengineering11070710"},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Rob, F., Schierova, D., Stehlikova, Z., Kreisinger, J., Roubalova, R., Coufal, S., Mihula, M., Jackova, Z., Kverka, M., and Thon, T. (2022). Association between ustekinumab therapy and changes in specific anti-microbial response, serum biomarkers, and microbiota composition in patients with IBD: A pilot study. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0277576"}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/4\/457\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:59:32Z","timestamp":1775725172000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/18\/4\/457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":45,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,4]]}},"alternative-id":["pharmaceutics18040457"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics18040457","relation":{},"ISSN":["1999-4923"],"issn-type":[{"value":"1999-4923","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]}}}